AUTHOR=Kloss Marlen , Moerke Caroline , Woitschach Franziska , Wulf Katharina , Illner Sabine , Schulz Steffen , Pauker Viktoria I. , Riedel Katharina , Grabow Niels , Ince Hüseyin , Reisinger Emil C. , Sombetzki Martina TITLE=Novel dalbavancin-PLLA implant coating prevents hematogenous Staphylococcus aureus infection in a minimally invasive mouse tail vein model JOURNAL=Frontiers in Bioengineering and Biotechnology VOLUME=10 YEAR=2022 URL=https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2022.1021827 DOI=10.3389/fbioe.2022.1021827 ISSN=2296-4185 ABSTRACT=
Infective/bacterial endocarditis is a rare but life-threatening disease with a hospital mortality rate of 22.7% and a 1-year mortality rate of 40%. Therefore, continued research efforts to develop efficient anti-infective implant materials are of the utmost importance. Equally important is the development of test systems that allow the performance of new materials to be comprehensively evaluated. In this study, a novel antibacterial coating based on dalbavancin was tested in comparison to rifampicin/minocycline, and the suitability of a recently developed mouse tail vein model for testing the implant coatings was validated. Small polymeric stent grafts coated with a poly-L-lactic acid (PLLA) layer and incorporated antibiotics were colonized with